The FDA is about two years away from approving psilocybin and MDMA for treating PTSD, but most of the general public has been in the dark. Read More
Marijuana Investing
Modern society is rediscovering plants used for ancient spiritual ceremonies. Gaining prominence is the psychedelic drug, ayahuasca. Read More
The increasingly popular practice of ingesting small doses of psychedelics to unleash creativity confers exciting investment opportunities. Read More
New York state and city have taken huge strides to mainstream marijuana, catalyzing cannabis expansion for the rest of the nation. Read More
We’re witnessing a renaissance in psychedelics research. The ramifications are profound for medicine, society, and investors. Read More
Research into LSD, psilocybin, and other psychedelics is accelerating, as biotech firms race to develop new drugs based on these substances. Read More
The U.S. House just passed amendments to expedite the use of psychedelics to treat addicted and traumatized vets and active military members. Read More
Huge coastal states aren’t the only places where cannabis is making headlines. Let’s turn to recent events in the Midwest. Read More
Pot sales soared during the July 4 festivities this year, as weed consumption becomes increasingly popular during the holidays. Read More
Despite the rise of a wide variety of new cannabis products, the most popular form remains traditional, smokeable flower. Read More